Integrated Network Pharmacology and UPLC/Q-TOF-MS Screen System to Exploring Anti-Inflammatory Active Components and Mechanism of Shunaoxin Pills.

Published in: Evidence-based complementary and alternative medicine : eCAM (2022)

Ligustilide, senkyunolide I, ferulic acid, and ligustrazine could be used as anti-inflammatory Q-markers to control the quality of SNX, and p38 and PDK1 might be potential targets of SNX in the treatment of CCI.

Keyphrases

anti inflammatory
neuropathic pain
high throughput
combination therapy
human health
risk assessment
smoking cessation